Ingredient record · Anti-vomiting medicine

Ondansetron: bans, restrictions and failed batches in India

Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026

2 entries containing Ondansetron are on India's banned-drugs list, and 2 are banned today. 51 batches of medicines containing Ondansetron failed a government lab test between March 2019 and July 2026, from 44 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.

2
Banned combinations in force
0
Other listed orders (stayed, restricted, quashed)
51
Batches failed a lab test
Jul 2026
Latest lab alert

On the banned-drugs list

Ondansetron on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.

Drug / combinationActionNotificationDateOrderStatus note
Ondansetron + ParacetamolFixed-dose combination · gi Banned S.O. 202(E) 11 January 2019 Other orders One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021.
Ondansetron + OmeprazoleFixed-dose combination · gi Banned S.O. 258(E) 11 January 2019 Other orders One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021.

Products that failed lab tests

Product names as printed by the testing labs, grouped. Open a product to see every batch number.

Most recent failed batches

Product Batch Manufacturer Reason declared NSQ Tested by Alert
Ondansetron Tablets IP 4 mg TB251158Mfg 2026-01 · Exp 2027-12 Agron Remedies Pvt. Ltd The sample received does not conform to i.p. 2022, ip addendum 2024 specification with respect to the test for related substances (total impurities) only.Related substances CDTL, HyderabadCDSCO lab Jul 2026
Ondansetron Tablets IP 4 mg TG252335Mfg 2025-11 · Exp 2027-10 Symbiosis Pharmaceuticals Pvt. Ltd. - (Plant-I) Symbiosis HouseHimachal Pradesh Assay & DissolutionAssay Lucknow LabState lab Jul 2026
Ondansetron Orally Disntagrating Tablets IP SPT252281Mfg 2025-10 · Exp 2027-09 Salus PharmaceuticalsHimachal Pradesh The sample has been declared as NSQ as it does not conform to IP standard with respect to Test for DisintegrationDisintegration RDTL. Bellary KarnatakaState lab Jul 2026
Ondansetron Orally Disintegration Tablets IP ST-34645Mfg 2024-10 · Exp 2026-09 Samay Pharma India Pvt. LtdHimachal Pradesh Disintegration TestDisintegration Lucknow LabState lab Jul 2026
Ondansetron Tablets IP ONST-1006Mfg 2026-07 · Exp 2027-06 Wings Biotech LLPHimachal Pradesh The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the test of Dissolution.Dissolution RDTL, ChandigarhCDSCO lab May 2026
Ondansetron Injection IP-2ml M-SET A25BI018CMfg 2025-11 · Exp 2027-10 Nixi Laboratories Pvt. LtdHimachal Pradesh AssayAssay King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab May 2026
Ondansetron Injection IP-2mg/ml TON-102Mfg 2025-11 · Exp 2027-10 Marc Laboratories Ltd. (Unit III)Himachal Pradesh pHpH King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab May 2026
Ondansetron Orally Disintegrating Tablets IP 8mg TG24-0742Mfg 2024-04 · Exp 2026-03 Athens Life SciencesHimachal Pradesh Assay, Disintegration & Dissolution.Assay DTL, JaipurState lab Mar 2026
Ondansetron Orally Disintegrating Tablets IP 4 mg OSD-2501Mfg 2025-11 · Exp 2027-10 Apple Formulations Pvt. LtdUttarakhand The sample does not conform to I.P.w.r.t. the tests for AssayAssay SDTL, AssamState lab Mar 2026
Ondansetron Hydrochloride Oral Solution IP ODS3602Mfg 2026-01 · Exp 2027-12 Modern LaboratoriesMadhya Pradesh pH and AssayAssay SDTL, TripuraState lab Mar 2026
Ondansetron Hydrochloride Oral Solution IP INT-01Mfg 2025-04 · Exp 2027-03 Sresan Pharmaceutical ManufacturerKarnataka Test for pHpH DTL, Bengaluru, KarnatakaState lab Feb 2026
Ondansetron Injection IP LA24174BMfg 2025-02 · Exp 2027-01 Symbiosis Pharmaceuticals Pvt. LtdHimachal Pradesh The sample does not comply as per I.P. 2022 with respect to the test for Sterility and BETSterility RDTL,GuwahatiCDSCO lab Jan 2026
Ondansetron and Ranitidine HCI Injection Vomibac R Injection 110525Mfg 2025-05 · Exp 2027-04 Pharma Chemico Laboratories DevghatHimachal Pradesh The sample received does not conform to manufacturer specification with respect to The test for pH only.pH CDTL-HyderabadCDSCO lab Dec 2025
Ondansetron Tablets IP Anset Tablets RBMT-921Mfg 2025-09 · Exp 2028-08 Ronald Pharmaceuticals (P) Ltd. B.No. 740-AGujarat The sample does not conform to I.P. 2022 with respect to The test for Related substances.Related substances CDTL, MumbaiCDSCO lab Dec 2025
Ondansetron Oral Solution IP K3ADY003Mfg 2025-04 · Exp 2027-03 Copmed Pharmaceuticals Pvt.LtdHimachal Pradesh pHpH DCL, TelanganaState lab Sep 2025
Showing 15 of 51 records

Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.